Search Results

Showing results 1981 - 1990 for weill cornell connect patient portal

Small Molecules that Protect Against Lipofuscin Toxicity to Prevent Blindness | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/small-molecules-protect-against-lipofuscin-toxicity

Iron Chelators for the Treatment of Adult Neuronal Ceroid Lipofuscinosis | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/iron-chelators-treatment-adult-neuronal-ceroid

Tumor-Derived Exomeres as Biomarkers for Cancer Detection and Monitoring | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/tumor-derived-exomeres-biomarkers-cancer-detection

Inhibitors of Fusion between Viral and Cell Membranes as well as Compositions and Methods of Using Them | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/inhibitors-fusion-between-viral-and-cell-membranes

Immunoglobulin D Enhances Antimicrobial Immunity by Activating Basophils | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/immunoglobulin-d-enhances-antimicrobial-immunity

3-phosphoglycerate Dehydrogenase (PHGDH) Inhibitors | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/3-phosphoglycerate-dehydrogenase-phgdh-inhibitors

VEGF for the Treatment of Peripheral Nerve Damage | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/vegf-treatment-peripheral-nerve-damage

Automated Intracytoplasmic Sperm Injection Device | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/automated-intracytoplasmic-sperm-injection-device

Reagents and Methods for Assaying Protein Synthesis and Amino Acid Transport | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/reagents-and-methods-assaying-protein-synthesis-and

Selective Inhibition of ERK2 for Persistent Inflammatory and Neuropathic Pain | Enterprise Innovation

...With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and...

https://innovation.weill.cornell.edu/industry-investors-partners/technology-portfolio/selective-inhibition-erk2-persistent-inflammatory

Showing results 1981 - 1990 for weill cornell connect patient portal